XML 55 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - 2018 Purchase Agreement and Indenture for Scilex and Bridge Loan Agreement - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 03, 2022
Feb. 16, 2022
Sep. 07, 2018
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Jun. 02, 2022
Feb. 15, 2022
Feb. 14, 2022
Oct. 05, 2018
Debt Instrument [Line Items]                        
Loss on debt extinguishment       $ 471,000 $ 584,000 $ 5,732,000 $ 6,695,000          
B. Riley Commercial Capital, LLC | Bridge Loan Agreement | Bridge Loan                        
Debt Instrument [Line Items]                        
Loss on debt extinguishment           (900,000)            
Amount of debt discount and debt issuance included in interest expense           900,000            
Short-term borrowings   $ 45,000,000.0                    
Interest rate per annum at event of default   15.00%                    
Debt instrument maturity date   Jun. 16, 2022                    
Senior Notes | Scilex Pharmaceuticals, Inc | Senior Secured Notes, Due 2026                        
Debt Instrument [Line Items]                        
Face value of loan     $ 224,000,000.0 74,877,000   74,877,000   $ 133,998,000        
Proceeds from issuance of senior long-term debt     $ 140,000,000.0                  
Principal amount to be purchased                     $ 20,000,000.0  
Loss on debt extinguishment           (4,800,000) (14,000,000.0)          
Principal payments           64,600,000 42,400,000          
Amount of debt discount and debt issuance included in interest expense       1,200,000 $ 1,900,000 3,100,000 $ 4,000,000.0          
Remaining principal amount $ 41,400,000                      
Redemption price as a percentage of outstanding principal 100.00%                      
Discharge of aggregate principal amount $ 28,000,000.0                      
Aggregate unrestricted cash equivalents                 $ 5,000,000.0      
Decrease in fair value       30,400,000   30,400,000            
Increase in carrying value       30,400,000   $ 30,400,000            
Debt instrument, gain recognized       $ 0                
Effective rate, description           Due to a decrease of $30.4 million in the fair value of the Scilex Notes Derivative caused by the Indenture Amendment, the carrying value of the Scilex Notes was increased by $30.4 million.            
Senior Notes | Scilex Pharmaceuticals, Inc | Senior Secured Notes, Due 2026 | ZTlido                        
Debt Instrument [Line Items]                        
Face value of loan               $ 28,000,000.0        
Additional principal payments, sales threshold               95.00%        
Increase to aggregate principal amount                   $ 28,000,000.0    
Expected additional principal payments, sales threshold           80.00%            
Senior Notes | Scilex Pharmaceuticals, Inc | Minimum | Senior Secured Notes, Due 2026                        
Debt Instrument [Line Items]                        
Debt instrument increased to face amount                       $ 25,000,000.0
Senior Notes | Scilex Pharmaceuticals, Inc | Maximum | Senior Secured Notes, Due 2026                        
Debt Instrument [Line Items]                        
Debt instrument increased to face amount                       $ 50,000,000.0
Subordinated Loan | Scilex Pharmaceuticals, Inc | Net Sales from Issue Date to December 31, 2021 Less than Specified Threshold | ZTlido                        
Debt Instrument [Line Items]                        
Face value of loan                     $ 35,000,000.0